O99.321
Drug use complicating pregnancy, first trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code O99.321 refers to cases where drug use complicates pregnancy during the first trimester, which comprises weeks 1 through 12 of gestation. This condition highlights the challenges and potential risks associated with prescription or recreational drug consumption by pregnant individuals. Managing drug use in pregnancy is crucial for safeguarding the health of both the mother and the developing fetus, as certain substances can lead to complications affecting pregnancy outcomes.
Causes & Symptoms
Clinical Causes: Use of recreational drugs such as opioids, cannabis, cocaine, or methamphetamine during early pregnancy. Consumption of prescribed medications that may have teratogenic or adverse effects if used improperly or without medical supervision. Substance dependence or addiction leading to continued drug use despite pregnancy awareness. Lack of access to appropriate prenatal care or addiction support services.
Key Symptoms: Nausea and vomiting (which may be confused with typical morning sickness). Unusual fatigue or tiredness. Mood changes or emotional disturbances. Signs of substance withdrawal or intoxication, such as tremors, agitation, or confusion. Unexplained weight changes or nutritional deficiencies. Potential physical signs related to specific substances, such as dilated pupils or skin changes.
Diagnostic & Treatment
Diagnosis Path: Screening questionnaires to assess substance use. Urine, blood, or hair tests to detect specific drugs or their metabolites. Monitoring pregnancy progression via ultrasounds and routine prenatal tests. Physical examinations to identify any physical signs of substance use.
Treatment Protocols: Counseling and psychological support to address underlying reasons for substance use. Referral to addiction specialists or substance abuse treatment programs tailored for pregnant women. Monitoring and managing withdrawal symptoms safely under medical supervision. Providing nutritional support and prenatal care to mitigate potential adverse effects. Education on the risks associated with drug use during pregnancy and the importance of abstinence. Coordination with obstetric care providers to closely monitor fetal development.
Clinical Advice & FAQs
Billing Guidance
Is O99.321 a billable ICD-10 code?
Yes, O99.321 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O99.321?
Clinical documentation must specify the nature of Drug use complicating pregnancy, first trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference